Literature DB >> 19387547

Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.

R Battistutta1.   

Abstract

Protein kinase CK2 is involved in many fundamental aspects of normal cell life, but it is also able to establish favourable conditions for tumorigenesis. CK2 is elevated in various cancers, it is a potent suppressor of apoptosis, it strongly promotes cell survival, it strengthens the multi-drug resistant phenotype and can be considered a valuable drug target for cancer therapy. In this review, the structural bases of CK2 inhibition deduced from the analysis of crystal structures of CK2alpha-inhibitor complexes are presented and discussed. The best ATP-competitive inhibitors show an adequate hydrophobic character, an excellent shape complementarity with the unique active site of CK2, and the ability to establish polar interactions with both the hinge region and the positive electrostatic area near the conserved water W1 and the Lys68-Glu81 salt bridge. The state of the art of non-ATP-competitive inhibitors is also presented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19387547     DOI: 10.1007/s00018-009-9155-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

1.  Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.

Authors:  Xiang Li; Varsha Rao; Jin Jin; Bin Guan; Kenna L Anderes; Charles J Bieberich
Journal:  J Proteome Res       Date:  2012-06-18       Impact factor: 4.466

Review 2.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

3.  Design and synthesis of CK2 inhibitors.

Authors:  Małgorzata Makowska; Edyta Łukowska-Chojnacka; Patrycja Wińska; Agnieszka Kuś; Aleksandra Bilińska-Chomik; Maria Bretner
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

Review 4.  Structural and functional determinants of protein kinase CK2α: facts and open questions.

Authors:  Roberto Battistutta; Graziano Lolli
Journal:  Mol Cell Biochem       Date:  2011-07-08       Impact factor: 3.396

5.  Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization.

Authors:  James E Dowling; Claudio Chuaqui; Timothy W Pontz; Paul D Lyne; Nicholas A Larsen; Michael H Block; Huawei Chen; Nancy Su; Allan Wu; Daniel Russell; Hannah Pollard; John W Lee; Bo Peng; Kumar Thakur; Qing Ye; Tao Zhang; Patrick Brassil; Vicki Racicot; Larry Bao; Christopher R Denz; Emma Cooke
Journal:  ACS Med Chem Lett       Date:  2012-01-24       Impact factor: 4.345

6.  The structure, properties, and nature of unconventional π halogen bond in the complexes of Al4(2-) and halohydrocarbons.

Authors:  Ran Li; Qingzhong Li; Jianbo Cheng; Wenzuo Li
Journal:  J Mol Model       Date:  2011-10-05       Impact factor: 1.810

7.  BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation.

Authors:  Alessandro Morotti; Cristina Panuzzo; Sabrina Crivellaro; Giovanna Carrà; Carmen Fava; Angelo Guerrasio; Pier Paolo Pandolfi; Giuseppe Saglio
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.

Authors:  Ming-Szu Hung; Yu-Ching Lin; Jian-Hua Mao; Il-Jin Kim; Zhidong Xu; Cheng-Ta Yang; David M Jablons; Liang You
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

9.  SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma.

Authors:  Vanesa Fernández-Sáiz; Bianca-Sabrina Targosz; Simone Lemeer; Ruth Eichner; Christian Langer; Lars Bullinger; Clemens Reiter; Julia Slotta-Huspenina; Sonja Schroeder; Anna-Maria Knorn; Julia Kurutz; Christian Peschel; Michele Pagano; Bernhard Kuster; Florian Bassermann
Journal:  Nat Cell Biol       Date:  2013-01       Impact factor: 28.824

10.  Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A.

Authors:  Stefania Sarno; Marco Mazzorana; Ryan Traynor; Maria Ruzzene; Giorgio Cozza; Mario A Pagano; Flavio Meggio; Giuseppe Zagotto; Roberto Battistutta; Lorenzo A Pinna
Journal:  Cell Mol Life Sci       Date:  2011-07-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.